oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Urethral instillations of clobetasol propionate and lidocaine: a promising treatment of urethral pain syndrome
Center for Clinical Research, Falun, Sweden; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Center for Clinical Research, Falun, Sweden; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Center for Clinical Research, Falun, Sweden; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.ORCID iD: 0000-0002-7407-9642
2016 (English)In: Clinical and Experimental Obstetrics & Gynecology, ISSN 0390-6663, Vol. 43, no 6, 803-807 p.Article in journal (Refereed) Published
Abstract [en]

Purpose: To evaluate topical treatment with clobetasol propionate and lidocaine in women with urethral pain syndrome (UPS) in a retrospective pilot study.

Materials and Methods: Urethral instillations of two ml clobetasol propionate cream and two ml lidocaine gel in 30 Caucasian women age 15-74 years with UPS between 1999 and 2006 were evaluated retrospectively. Instillations were given approximately once a week until the patient improved. Between one and 15 (median three) instillations were given. In substudy I a review was undertaken of the medical records to register the treatment effect at the end of the treatment (the last instillation) and any relapses six months thereafter. Substudy II was a follow-up at least five years after last instillation based on medical records and a written questionnaire.

Results: Substudy I (n=30): By the end of the treatment 18 women had no symptoms and 12 were improved. Five patients had relapsed within six months. Substudy II (n=28): Twenty-eight women responded to the questionnaire. Four women remained with no symptoms, 18 remained improved, and six had the same symptoms as before treatment. Twenty women thought the treatment was very effective, five rather effective, and three women reported poor effect. Twenty-six women would ask for retreatment if a relapse occurred, two patients would not. No side effects, except transient pain, were reported.

Conclusions: This retrospective study and long-term follow-up suggests that urethral instillation of clobetasol propionate and lidocaine is effective in treating women with UPS. Randomized control studies are warranted.

Place, publisher, year, edition, pages
I. R. O. G. Canada, Inc. , 2016. Vol. 43, no 6, 803-807 p.
Keyword [en]
Clobetasol, Lidocaine, Urethral pain syndrome, Urethral syndrome, Urethritis
National Category
Obstetrics, Gynecology and Reproductive Medicine
Identifiers
URN: urn:nbn:se:oru:diva-57635DOI: 10.12891/ceog3178.2016ISI: 000388785400005Scopus ID: 2-s2.0-85008608207OAI: oai:DiVA.org:oru-57635DiVA: diva2:1094859
Available from: 2017-05-11 Created: 2017-05-11 Last updated: 2017-05-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Lindström, Annika K.
Obstetrics, Gynecology and Reproductive Medicine

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 14 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf